Diazepam Nasal Spray (Valtoco®) UpdatesEarlier this year, Valtoco (diazepam nasal spray) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of seizure clusters and acute repetitive seizures. The makers of Valtoco have recently announced that it will now be available in pharmacies nationwide. Read the full press release from Neurelis, Inc. here.Valtoco is currently approved for adult and pediatric patients six years of age and older. If you have questions about this medicine, please email info@neurelis.com
FDA Announced diazepam shortage
The FDA announced that there is an ongoing shortage of both brand and generic forms of diazepam rectal gel. This medication is used for rescue therapy in people with epilepsy, including children. The Epilepsy Foundation strongly encourages you to speak with your...